Hypertension arising before or in the first half of pregnancy requires active management to protect both the pregnant individual and the fetus. This protocol addresses the specific scenario of pre-existing or early-onset elevated blood pressure in pregnancy.
This protocol applies to pregnant individuals with chronic hypertension — defined as prepregnancy hypertension or systolic BP 140–159 mm Hg and/or diastolic BP 90–109 mm Hg prior to 20 weeks of gestation — or with gestational hypertension. Antihypertensive therapy is indicated to prevent maternal and perinatal morbidity and mortality.
Pregnant individuals with chronic hypertension (defined as prepregnancy hypertension or SBP 140-159 mm Hg and/or DBP 90-109 mm Hg prior to 20 weeks gestation) should receive antihypertensive therapy to achieve BP <140/90 mm Hg to prevent maternal and perinatal morbidity and mortality.
For individuals with hypertension who are planning a pregnancy or who become pregnant, labetalol and extended-release nifedipine are preferred agents to treat hypertension and minimize fetal risk.
Individuals with hypertension who are planning a pregnancy or who become pregnant should be counseled about the benefits of low-dose (81 mg/day) aspirin to reduce the risk of preeclampsia and its sequelae.
View source ↗